Optimizing MS therapy - current treatment models and future options
March 12-13, 2010
Rome, Italy
FRIDAY, MARCH 12, 2010
14:00 Opening
Giancarlo Comi, SSIF Scientific Committee President, Italy
14:10 Welcome and introduction
David Bates, UK, and Carlo Pozzilli, Italy
Session I - Updates on MS therapy
Session Chairs: David Bates, UK and Eva Havrdová, Czech Republic
14:20 Current treatments in relapsing remitting MS
Patrick Vermersch, France
14:40 Emerging therapies for relapsing remitting MS
Jerry Wolinsky, USA
15:00 Discussion and concluding remarks
David Bates, UK
15:20 Coffee break
Session II - Freedom from disease activity
Session Chairs: David Bates, UK and Carlo Pozzilli, Italy
15:40 The disease free concept in MS
Fred Lublin, USA
16:10 Induction therapy schemes for the treatment of MS
Eva Havrdová, Czech Republic
16:30 Add-on therapies – current options and future directions
Ludwig Kappos, Switzerland
16:50 Discussion and concluding remarks
Carlo Pozzilli, Italy
17:10 Coffee break
Session III - Treatment individualization
Session Chairs: Mefkure Eraksoy, Turkey and Maria Trojano, Italy
17:30 Predicting disease evolution in the individual patient
Mar Tintorè, Spain
17:50 Predicting disease activity and course in the individual patient
Per Soelberg Sørensen, Denmark
18:10 Present and future perspectives in treatment individualization
Giancarlo Comi, Italy
18:30 Discussion and concluding remarks
Maria Trojano, Italy
SATURDAY, MARCH 13, 2010
Session IV - Resetting the immune system: from immunomodulation to intensive immunosuppression
Session Chairs: David Bates, UK and Mefkure Eraksoy, Turkey
09:00 Escalating therapy
Bernd Kieseier, Germany
09:20 Bone marrow transplant in patients with MS
Gianluigi Mancardi, Italy
09:40 Discussion and concluding remarks
Mefkure Eraksoy, Turkey
Session V - Primary progressive MS an unmet therapeutic need
Session Chairs: David Bates, UK and Catherine Lubetzki, France
10:00 Predicting disease progression in patients with PPMS
Alan J. Thompson, UK
10:20 Clinical trials in PPMS – a review
Douglas Goodin, USA
10:40 Discussion and concluding remarks
Catherine Lubetzki, France
11:00 Coffee break
Session VI - Case studies
Session Chair: David Bates, UK
11:20 Case Studies
Case #1: CIS
David Bates, UK
Case #2: Failing first line therapy
Carlo Pozzilli, Italy
Case #3: Aggressive disease RRMS
Mar Tintorè, Spain
12:40 Discussion and concluding remarks
David Bates, UK
13:00 Closing remarks
David Bates, UK and Carlo Pozzilli, Italy
13:10 End of the conference
